From the Editor's Desk
Author
Jennifer E. Taylor, Ph.D., M.B.A.
Rush Medical Center and University
The Journal of Research Administration (JRA) is the premier scholarly publication in research administration and management. We publish timely, essential work that enhances the knowledge base for research administration and supports research administrators worldwide, making JRA a crucial resource for career development and for advancing the field’s overall knowledge. By publishing peer-reviewed scholarly articles, contributors not only advance their own careers but also elevate our profession.
I am excited to share this special issue of the Journal of Research Administration with our readers and with members of the Society for Research Administration International (SRAI). This issue, focused on Clinical Trials, highlights the crucial role that research administrators often play—either through their own efforts or in partnership with other administrative and academic units—in advancing the pursuit of discovery surrounding effective, cutting-edge treatments for health challenges affecting individuals and families around the world. In our call for submissions for this special edition, we welcomed submissions from those in healthcare or other research environments, whether working in central administration, at the unit and departmental levels, or within other organizational units. The quality of the submissions and the insights they provided were informative and engaging. Nonetheless, we received fewer submissions than we had hoped. The manuscripts published in this issue only scratch the surface of a significant yet underrepresented area, and we would love to believe that this publication inspires more researchers involved in clinical trial administration to develop scholarly manuscripts on their work and share them with the broader field of research administration.
Our special issue starts with the article entitled “Self-Auditing: Keys to successfully identifying knowledge gaps for effectively managing industry-sponsored clinical trials to reduce financial and compliance risks” by Jennifer Harry, Ethan Arana, and Marilyn Marshall of Seattle Children’s Research Institute (SCRI). They provide an in-depth case study examining SCRI’s self-audit of eleven private-industry-funded clinical trials, with a specific focus on post-award financial management. Their main goal was to assess the effectiveness of new systems and processes in reducing financial and compliance risks for the organization. Their findings reveal opportunities for research administrators to enhance risk-reduction efforts and improve training initiatives, emphasizing the importance of ongoing training for research administrators, especially in adapting to new systems and policy changes. The authors also share key lessons learned—not only for their own institution, but also for research administrators who handle the financial management of clinical trials across healthcare settings.
In the next manuscript, Krishna B. Bhadriraju and Dr. Mani Cheruvu from St. Francis Health System provide a detailed SWOT analysis of global clinical trials and their wider ecosystem. This thought-provoking report, titled “A Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of Global Clinical Trials (GCTs),” acts as a call for a more robust conceptual and empirical basis for Global Clinical Trials (GCTs). The authors argue that such effort is necessary because their analysis shows that GCTs, vital tools for improving healthcare worldwide, face unique challenges that can hinder success and affect data reliability. Among these challenges are the ongoing complexities of operating across diverse regulatory, technical, cultural, and socioeconomic environments. They conclude by emphasizing the urgent need for a more comprehensive, inclusive, and globally consistent framework to guide GCTs.
The manuscript that follows, authored by Holly Zink, Jennifer Goldman, Jacob Sosnoff, Lisa M. Harlan-Williams, and Nikki Nollen from the University of Kansas Medical Center and Children’s Mercy Hospital of Kansas City, guides the development of effective leaders in the clinical trials workforce and presents at least one potentially effective approach to achieve this. Their study, “Cultivating Future Leaders: A Review of the Role of Mentorship in the Clinical Trials Research Workforce,” discusses the process and findings of a scoping review on effective mentor training. They identify and explore several significant themes: Competency-Based Mentorship, Cultural Responsiveness, Evidence-Based Curriculum, and Impact on Research Productivity and Personal Development. In their discussion of the review results, they offer guidance on strengthening mentorship, supported by evidence-based tools and continuous feedback mechanisms. In their words, “the review provides a thorough overview of current mentorship practices, illustrating the multifaceted nature of effective clinical translational research mentorship and offering insights into strategies for developing successful clinical translational research mentorship programs.”
In the manuscript entitled “Optimizing ClinicalTrials.gov Processes for Research Administrators,” Anita Trupiano of Rutgers Cancer Institute and Rani Muthukrishnan of Texas A&M University-San Antonio examine the requirements placed on research administrators engaged in clinical trials as they relate to the public-facing website, ClinicalTrials.gov. This critical public U.S. government database allows researchers, patients, and the public to access information about clinical trials, including their purpose, eligibility, locations, and outcomes, making it a powerful platform for ensuring transparency and accountability in clinical research. Ensuring the success and compliance of projects registered in this database requires contributions from various stakeholders, including research administrators in multiple roles within healthcare settings. Through interviews with professionals across institutions, this article presents the challenges, best practices, and proposed strategies for optimizing the processes that Research Administrators use to maintain a robust ClinicalTrials.gov presence. This submission is an important resource for administrators who interact with ClinicalTrials.gov.
The final article in this special issue is mine, titled “Enhancing the Research Administration of Clinical Trials in Medical Centers: Challenges, Opportunities, and Strategic Directions.” It was developed to synthesize current knowledge on the major challenges and promising opportunities shaping clinical trial management across leading medical centers and decentralized sites. The study also aims to identify strategic themes and evidence-based recommendations to encourage further research in this understudied area. The discussion highlights the barriers administrators encounter in managing clinical trials and provides guidance on effectively tackling issues such as administrative burdens, delays in activation and completion, and, at times, failures in clinical trial management.
Overall, I hope that this special issue will encourage continuing focus on the enhancement of the administration of clinical trials and future submissions to JRA to serve as a valuable resource for innovative and effective strategies dedicated to improving clinical trial efforts across the profession. In my previously discussed manuscript, I mention that “clinical trials are essential building blocks for the development of evidence-based medicine. They are a critical step that helps move us from fundamental scientific discoveries to applied, phased clinical trials and, if successful, to informing the enhancement of what becomes state-of-the-art care.” This is just one of the key areas where research administration contributes to improving the well-being of people worldwide.
I must conclude this letter by noting that this is my final issue as Editor-in-Chief for the Journal of Research Administration. I have been privileged to work with the dedicated members of the Editorial Board, who devote countless hours of hard work without compensation to guide authors from submission to acceptance, all the while upholding the journal's excellence. I cannot thank them enough for their friendship, support, and trust. I also want to thank the staff of SRAI and JRA, who provide essential support for the journal's continued work. As JRA moves forward under the new editorial leadership of Holly Zink, I look forward to reading the important contributions of our future authors, who provide the immensely valuable contributions of their colleagues, and the field of research administration overall. We truly appreciate all the work that they do. If I have overlooked thanking any of you who have assisted me during my time as Editor-in-Chief, please accept my apologies. It has been an honor to be entrusted with this role.